SCHEMBL2476960

SCHEMBL2476960

CC(=O)C(N=Nc1ccc(OC(F)F)cc1)C(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.46
GFER P55789 1/20 0.46
ADAM17 P78536 1/20 0.46
MAPT P10636 3/20 0.45
ALDH1A1 P00352 3/20 0.45
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
LMNA P02545 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 2/20 0.43
PKM P14618 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 1/20 0.38
ATM Q13315 1/20 0.38
ACACB O00763 1/20 0.37
POLB P06746 1/20 0.37
DRD1 P21728 1/20 0.37
ELANE P08246 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2476956 1.00 ALOX15 (0.46) ALOX15GFERADAM17MAPTALDH1A1
SCHEMBL2479591 0.73 CYP1A2 (0.58) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL2479589 0.73 CYP1A2 (0.58) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL3506756 0.70 CYP1A2 (0.39) MAPTALDH1A1LMNANPC1RAB9A
SCHEMBL3506760 0.70 CYP1A2 (0.39) MAPTALDH1A1LMNANPC1RAB9A
SCHEMBL1906677 0.70 ALOX15 (0.61) ALOX15GFERADAM17MAPTALDH1A1
SCHEMBL26231864 0.70 LMNA (0.57) ALOX15GFERADAM17MAPTALDH1A1
SCHEMBL13306097 0.69 HTT (0.50) ALOX15MAPTALDH1A1MEN1KMT2A
SCHEMBL5698975 0.68 NPC1 (0.46) MAPTMEN1KMT2ALMNANPC1
SCHEMBL11065049 0.67 DRD1 (0.56) ALOX15GFERADAM17MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373641-B1 PYRIDAZINONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2012-12-19 EP disclosed
US-8178538-B2 Pyridazinones HOFFMANN-LA ROCHE INC. (US) 2012-05-15 US disclosed
EP-2373641-A1 PYRIDAZINONE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2011-10-12 EP disclosed
US-20100152193-A1 PYRIDAZINONES HOFFMANN-LA ROCHE, INC. 2010-06-17 US disclosed
WO-2010063610-A1 PYRIDAZINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152193-A1 PYRIDAZINONES PDE5A, PDE3A, PDE10A ALOX15 3078/4885GFER 3710/4885ADAM17 1049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.